NDAINJECTIONINJECTABLEPriority Review
Approved
Jan 1960
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
Priority Review
CARBOCAINE (mepivacaine hydrochloride) by Pfizer is clinical pharmacology mepivacaine hydrochloride is a potent local anesthetic whose effectiveness and safety have been well established in human medicine and dentistry. First approved in 1960.
Drug data last refreshed 19h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CARBOCAINE is a potent local anesthetic (mepivacaine hydrochloride) with 2-2.5x the anesthetic activity of procaine and efficacy comparable to or exceeding lidocaine. Administered by injection, it produces rapid onset local anesthesia lasting several hours, enabling extended surgical procedures without delay. Originally developed for veterinary use, it demonstrates excellent tissue compatibility and may be enhanced with epinephrine for prolonged effect.
LOE Approaching
As a legacy product approaching loss of exclusivity with 30% competitive pressure, the brand team is likely small and focused on market defense rather than expansion.
Mechanism of Action
CLINICAL PHARMACOLOGY Mepivacaine hydrochloride is a potent local anesthetic whose effectiveness and safety have been well established in human medicine and dentistry. Laboratory and clinical studies in animals have confirmed its value in veterinary medicine. Its anesthetic activity is two to two…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on CARBOCAINE offers limited career growth given its mature LOE status and lack of linked job openings; roles are primarily defensive and focused on market maintenance. This is an ideal assignment for professionals seeking stable, lower-pressure work or those building manufacturing and supply chain expertise in established products.
Worked on CARBOCAINE at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.